Skip to content

A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma

A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05962892
Enrollment
600
Registered
2023-07-27
Start date
2024-02-01
Completion date
2028-02-28
Last updated
2024-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Papillary Thyroid Carcinoma, Thermal Ablation

Keywords

Papillary Thyroid Carcinoma, cohort, Thermal Ablation, Recurrence

Brief summary

A prospective cohort of papillary thyroid carcinoma(PTC), patients who received thermal ablation in our hospital since February 2023 was established as the study object. Preoperative and postoperative demographic data, ultrasonography, other relevant laboratory tests, and thyroid disease-related scales such as fatigue, depression, and stress were collected. The influencing factors of PTC recurrence were analyzed.

Interventions

OTHERNo Intervention

No Intervention

Sponsors

Beijing Friendship Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

①≥18 years old; ② Obtain informed consent; ③ Ultrasonography showed that malignant nodules were single, the maximum diameter of nodules was ≤1cm and the distance from the capsule was ≥2mm. ④ no lymph node metastasis or other extra-glandular metastasis in the neck; ⑤ PTC was confirmed by fine needle puncture pathology; ⑥ Patients who do not meet Article 3, who still strongly request thermal ablation while fully informing the patient of the risk of recurrence, and who have been clinically assessed to be technically capable of thermal ablation

Exclusion criteria

① Pregnant or lactating patients; ② Patients with other malignant tumors and not suitable for ablation by clinical evaluation; ③ Patients who cannot tolerate surgery; ④ Patients with cognitive impairment and other conditions who cannot accurately fill in thyroid-related questionnaires.

Design outcomes

Primary

MeasureTime frameDescription
the recurrence of PTC1 to 5 yearsthe recurrence of PTC during follow-up

Countries

China

Contacts

Primary ContactXianquan Shi, PhD
sonoshixq@ccmu.edu.cn18510085125

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026